A UCSF-led commentary is calling attention to a little-known regulatory loophole that allows unsafe and untested medical devices to reach the marketplace and harm patients.
January 04, 2013
A team of UCSF researchers have conducted the most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness.
April 24, 2012
According to a provocative new UCSF analysis, patients are all too often left in the dark about how and what hospitals charge for their medical care – even in the face of a mounting push nationally for consumers to have a voice in how their health care dollars are spent.
June 24, 2011
Former NFL player Harris Barton will present a $2.5 million check on behalf of Champion Charities to Dr. Michael Prados of the University of California, San Francisco’s Brain Tumor Research Center, to support its mission to eradicate brain disease.
September 28, 2010
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
August 05, 2010
Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.